Quantum licensee Unbuzzd Wellness commences Reg D capital raise campaign

Quantum BioPharma announced that Unbuzzd Wellness announced the launch of its previously announced Regulation D 506(c) offering to raise up to $5M to fund growth and establish a path to a possible initial public offering. This will not impact or dilute Quantum BioPharma shareholders. Quantum BioPharma maintains an anti-dilution provision which ensures its ownership in Unbuzzd Wellness Inc. is 25% until unbuzzd reaches $1,000,000,000 in valuation. Once Unbuzzd Wellness Inc. goes public, Quantum BioPharma will be able to access non-dilutive capital through its ownership. Unbuzzd has partnered with MZ Digital, a global leader in marketing, and Dealmaker, a leading online platform for raising capital to conduct the capital raise campaign. The Regulation D offering allows Unbuzzd to raise capital by selling and issuing securities to accredited investors without a cap on the amount raised. Investments can be made with traditional payments or with cryptocurrency payments: the latter through ALT5 Pay’s digital payments platform.